A number of other equities analysts have also weighed in on the company. Bank of America lowered Healthpeak Properties from a buy rating to a neutral rating and set a $32.00 target price on the stock. in a research report on Thursday, May 19th. Credit Suisse Group upped their target price on Healthpeak Properties from $37.00 to $38.00 and gave the stock a neutral rating in a research report on Monday, April 4th. Capital One Financial started coverage on Healthpeak Properties in a research report on Friday, June 3rd. They set an equal weight rating and a $34.00 target price on the stock. Finally, Morgan Stanley lowered their price target on Healthpeak Properties from $34.50 to $32.50 and set an equal weight rating for the company in a research report on Wednesday, June 1st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of Hold and an average price target of $35.25.
Shares of NYSE:PEAK opened at $25.31 on Monday. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 0.91. Healthpeak Properties has a twelve month low of $23.23 and a twelve month high of $37.69. The stock’s 50 day moving average is $29.77 and its 200-day moving average is $32.59. The firm has a market capitalization of $13.66 billion, a price-to-earnings ratio of 32.04, a PEG ratio of 2.70 and a beta of 0.74.
The business also recently declared a quarterly dividend, which was paid on Friday, May 20th. Investors of record on Monday, May 9th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 4.74%. The ex-dividend date was Friday, May 6th. Healthpeak Properties’s payout ratio is currently 151.90%.
A number of large investors have recently made changes to their positions in PEAK. Norges Bank bought a new position in Healthpeak Properties in the 4th quarter valued at $464,976,000. Invesco Ltd. grew its stake in Healthpeak Properties by 96.4% in the 1st quarter. Invesco Ltd. now owns 11,512,029 shares of the company’s stock valued at $395,209,000 after purchasing an additional 5,650,120 shares during the period. State Street Corp grew its stake in Healthpeak Properties by 8.8% in the 1st quarter. State Street Corp now owns 38,709,498 shares of the company’s stock valued at $1,328,897,000 after purchasing an additional 3,142,939 shares during the period. Centersquare Investment Management LLC grew its stake in Healthpeak Properties by 112.5% in the 4th quarter. Centersquare Investment Management LLC now owns 5,467,708 shares of the company’s stock valued at $197,329,000 after purchasing an additional 2,894,300 shares during the period. Finally, Eaton Vance Management grew its stake in Healthpeak Properties by 226.9% in the 1st quarter. Eaton Vance Management now owns 3,616,528 shares of the company’s stock valued at $124,156,000 after purchasing an additional 2,510,133 shares during the period. Hedge funds and other institutional investors own 95.98% of the company’s stock.
Healthpeak Properties Company Profile (Get Rating)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.
- Get a free copy of the StockNews.com research report on Healthpeak Properties (PEAK)
- Zai Lab Stock Has Fallen to Value Levels
- Are These Cheap Copper Stocks Right For Your Portfolio?
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.